INFLIXIMAB PLUS AZATHIOPRINE AND QUICK STEROIDS DISCONTINUATION VERSUS AZATHIOPRINE PLUS STEROIDS IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS RESPONDING TO INTRAVENOUS STEROIDS: A PARALLEL, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL

Aurelien Amiot  ¹     Philippe Seksik  ²     Antoine Meyer  ²     Alexandre Nuzzo  ³     Pauline Wils  ⁴     Romain Altwegg  ⁵     Lucine Vuitton  ⁶     Laurianne Plastaras  ⁷     Adrien Nicolau  ⁸     Anthony Buisson  ⁹     Nicolas DUVEAU  ¹⁰     David Laharie  ¹¹     Médina Boualit  ¹²     Matthieu Allez  ¹³     Sylvie Rajca  ¹⁴     Elise Chanteloup  ¹⁵     Guillaume Bouguen  ¹⁶     Eric Vicaut  ¹⁷     Laurent Peyrin-Biroulet  ^18    
1 Bicetre Hospital, APHP, Le Kremlin Bicêtre, France
² Gastroenterology and Nutrition Unit, Paris, France
³ Beaujon Hospital, Paris, France
⁴ CHRU Lille, Lille Cedex, France
⁵ Hopital Saint Eloi, Montpellier Cedex 5, France
⁶ Besançon University Hospital, Courbevoie, France
⁷ CHU Colmar, Colmar, France
⁸ Nice, Nice, France
⁹ CHU Estaing Clermont-Ferrand, Clermont-ferrand, France
¹⁰ Hopital Victor Provo, Roubaix Cedex 1, France
¹¹ CHU de Bordeaux Hopital Haut-Leveque, Pessac Cedex, France
¹² CH Valenciennes, Valenciennes Cedex, France
¹³ Hopital Saint-Louis APHP, Université Denis Diderot Paris 7, Paris, France
¹⁴ Hopital Saint Antoine, Paris Cedex 12, France
¹⁵ GH Paris Saint-Joseph, Paris, France
¹⁶ CHU Pontchaillou, Rennes, France
¹⁷ Fernand Widal Hospital, Paris, France
¹⁸ Nancy University Hospital, Vandoeuvre-les-Nancy, France

Topic
IBD

Session
The switch game: Optimal treatment modalities in IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)